Liver metastases are one of the most common sites of cancer spread, and the survival rates are very low. However, Cancer Center at Illinois (CCIL) researchers recently identified a new promising therapeutic target.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗